×
S&P 500   3,911.74
DOW   31,500.68
QQQ   294.61
S&P 500   3,911.74
DOW   31,500.68
QQQ   294.61
S&P 500   3,911.74
DOW   31,500.68
QQQ   294.61
S&P 500   3,911.74
DOW   31,500.68
QQQ   294.61
LON:GNS

Genus Share Forecast, Price & News

GBX 2,504
+28.00 (+1.13%)
(As of 06/24/2022 12:00 AM ET)
Add
Compare
Today's Range
2,504
2,552
50-Day Range
2,234
2,762
52-Week Range
2,186
6,310
Volume
98,907 shs
Average Volume
100,456 shs
Market Capitalization
£1.65 billion
P/E Ratio
44.56
Dividend Yield
1.28%
Price Target
GBX 5,348
30 days | 90 days | 365 days | Advanced Chart

Receive GNS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Genus and its competitors with MarketBeat's FREE daily newsletter.

GNS Stock Forecast (MarketRank)

Overall MarketRank

1.92 out of 5 stars

Analyst Opinion: 3.3Community Rank: 4.7Dividend Strength: 1.7Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -
Genus logo

About Genus (LON:GNS)

Genus plc operates as an animal genetics company in North America, Latin America, the United Kingdom, rest of Europe, the Middle East, Russia, Africa, and Asia. The company operates through three segments: Genus PIC, Genus ABS, and Genus Research and Development. It sells sows, boars, and semen to breed pigs with various characteristics for pork production under the PIC brand. The company also sells bull semen and embryos to breed calves with various characteristics for milk and beef production under the ABS, Genus, and Bovec brands. In addition, it offers semen sexing, in reproductive, and other technical services to farmers. Genus plc has a strategic collaboration with Beijing Capital Agribusiness Co. Ltd to pursue the porcine reproductive respiratory syndrome virus resistant regulatory and development work in China. The company was incorporated in 1994 and is based in Basingstoke, the United Kingdom.

GNS Stock News Headlines

See More Headlines

Industry, Sector and Symbol

Industry
Biotechnology
Sub-Industry
N/A
Sector
Medical
CIK
N/A
Fax
N/A
Employees
3,400
Year Founded
N/A

Company Calendar

Ex-Dividend for 3/31 Dividend
3/03/2022
Dividend Payable
3/31/2022
Today
6/24/2022
Next Earnings (Estimated)
9/08/2022

Price Target and Rating

Average Stock Price Forecast
GBX 5,310
High Stock Price Forecast
GBX 5,740
Low Stock Price Forecast
GBX 4,500
Forecasted Upside/Downside
+113.6%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.6
Research Coverage
4 Analysts

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
£569.80 million
Cash Flow
GBX 69.98 per share
Book Value
GBX 778.60 per share

Miscellaneous

Free Float
N/A
Market Cap
£1.65 billion
Optionable
Not Optionable
Beta
N/A














Genus Frequently Asked Questions

Should I buy or sell Genus stock right now?

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Genus in the last twelve months. There are currently 2 hold ratings and 2 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "moderate buy" Genus stock.
View analyst ratings for Genus
or view top-rated stocks.

What is Genus' stock price forecast for 2022?

4 Wall Street analysts have issued 1 year target prices for Genus' shares. Their GNS stock forecasts range from GBX 4,500 to GBX 5,740. On average, they expect Genus' stock price to reach GBX 5,310 in the next year. This suggests a possible upside of 112.1% from the stock's current price.
View analysts' price targets for Genus
or view top-rated stocks among Wall Street analysts.

How has Genus' stock price performed in 2022?

Genus' stock was trading at GBX 4,938 at the beginning of the year. Since then, GNS shares have decreased by 49.3% and is now trading at GBX 2,504.
View the best growth stocks for 2022 here
.

When is Genus' next earnings date?

Genus is scheduled to release its next quarterly earnings announcement on Thursday, September 8th 2022.
View our earnings forecast for Genus
.

How often does Genus pay dividends? What is the dividend yield for Genus?

Genus announced a dividend on Thursday, February 24th. Shareholders of record on Thursday, March 3rd will be given a dividend of GBX 10.30 per share on Thursday, March 31st. This represents a dividend yield of 0.33%. The ex-dividend date of this dividend is Thursday, March 3rd. The official announcement can be seen at this link.
View Genus' dividend history
.

Is Genus a good dividend stock?

Genus(LON:GNS) pays an annual dividend of GBX 0.32 per share and currently has a dividend yield of 1.28%. The dividend payout ratio of Genus is 0.57%. This payout ratio is at a healthy, sustainable level, below 75%.
View Genus' dividend history.

Who are Genus' key executives?

Genus' management team includes the following people:
  • Mr. Stephen Wilson, CEO & Exec. Director (Age 62, Pay $1.67M)
  • Ms. Alison Henriksen, CFO & Exec. Director (Age 55, Pay $1.13M)
  • Dr. William Christianson, Chief Operating Officer
  • Dr. Elena Rice, Head of R&D and Chief Scientific Officer
  • Mr. Dan Hartley, Group Gen. Counsel & Company Sec.
  • Ms. Angelle R. Rosata, Group HR Director
  • Mr. Jerry Thompson, Chief Operating Officer of Genus ABS Beef
  • Dr. Nate Zwald, Chief Operating Officer of Genus ABS Dairy
  • Ms. Janet Duane, Group Financial Controller

What other stocks do shareholders of Genus own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Genus investors own include Clinigen Group (CLIN), Glencore (GLEN), Tesco (TSCO), AstraZeneca (AZN), British American Tobacco (BATS), Cronos Group (CRON), Dairy Crest Group (DCG), Debenhams (DEB), Diageo (DGE) and Experian (EXPN).

What is Genus' stock symbol?

Genus trades on the London Stock Exchange (LON) under the ticker symbol "GNS."

How do I buy shares of Genus?

Shares of GNS and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

What is Genus' stock price today?

One share of GNS stock can currently be purchased for approximately GBX 2,504.

How much money does Genus make?

Genus (LON:GNS) has a market capitalization of £1.65 billion and generates £569.80 million in revenue each year.

How many employees does Genus have?

Genus employs 3,400 workers across the globe.

How can I contact Genus?

Genus' mailing address is Matrix House, Basing View, BASINGSTOKE, RG21 4DZ, United Kingdom. The official website for Genus is www.genusplc.com. The company can be reached via phone at +44-1256-347100.

This page (LON:GNS) was last updated on 6/25/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer.